Physician profile
Eric J Rashba
NPI 1659311868
$9,853.67
in general payments reported to CMS, 2019-2025
17 companies · $1,300 in 2025
The $1,300 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $17.11 · 2021: $84.89 · 2022: $774 · 2023: $1,042 · 2024: $5,537 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,521 · Food and Beverage: $3,338 · Consulting Fee: $1,000 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,521.44 |
| Food and Beverage | $3,338.13 |
| Consulting Fee | $1,000.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,074.95 | 2019-2025 | Aveir, Amplatzer Amulet, Amplatzer Torqvue 45 X 45 |
| Medtronic, INC. | $2,779.28 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Boston Scientific Corporation | $1,104.71 | 2019-2025 | Watchman Flx, Acuity Steerable, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $581.26 | 2024 | |
| Philips North America LLC | $456.07 | 2021-2025 | (Ck4) Mcot, Ecc Solutions, (Cm9) Amb Mon & Diag Und |
| Biosense Webster, INC. | $239.18 | 2019 | |
| Irhythm Technologies, INC. | $231.52 | 2022 | |
| Atricure, INC. | $121.52 | 2023-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Impulse Dynamics (USA) INC. | $71.08 | 2023 | Optimizer |
| Medtronic Vascular, INC. | $62.66 | 2019 | |
| Kestra Medical Technology Services, INC. | $45.79 | 2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $23.30 | 2023 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Pfizer INC. | $16.31 | 2023 | |
| Novartis Pharmaceuticals Corporation | $13.08 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12.96 | 2023 | Camzyos |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rashba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.